BioRestorative Therapies Director Jatinder Dhaliwal Reports No Securities Ownership

This SEC Form 3 filing reports that Jatinder Dhaliwal, a director of BioRestorative Therapies, Inc. (BRTX), has no securities ownership in the company as of June 10, 2026. The filing indicates Dhaliwal serves as a director but does not hold officer positions or own 10% or more of the company's securities. The document was signed on June 18, 2026, and reports a period ending June 10, 2026. Form 3 filings are required for initial statements of beneficial ownership by directors, officers, and principal shareholders, making this disclosure significant for tracking insider ownership positions and potential conflicts of interest.